Moody’s assigns ‘A3’ to Mount Sinai Hospital’s bonds

Moody’s Investors Service assigned its “A3” rating to New York City-based Mount Sinai Hospital’s proposed $356 million series 2017.

Advertisement

In addition, Moody’s affirmed its “A3” rating on MSH’s outstanding bonds, affecting $315 million of debt.

The affirmation and assignment are a result of several factors, including MSH’s strong market position, manageable leverage, and improved operating margins and liquidity metrics. Moody’s also acknowledged the MSH’s weak cashflow, highly competitive service area and increased capital spending period.

The outlook is stable, reflecting Moody’s expectation that MSH’s sustained operating performance, maintained liquidity metrics and fundraising capabilities will offset the period of high capital spending.

More articles on healthcare finance:
10 grants, donations to healthcare organizations in November
Grady Memorial Hospital: $10M away from $165M fundraising goal
Fitch: Rating downgrades will likely outweigh upgrades for US healthcare companies in 2018

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.